1. Home
  2. ALT vs CCIX Comparison

ALT vs CCIX Comparison

Compare ALT & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$3.55

Market Cap

415.3M

Sector

Health Care

ML Signal

HOLD

CCIX

Churchill Capital Corp IX Ordinary Shares

HOLD

Current Price

$10.65

Market Cap

390.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALT
CCIX
Founded
1997
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
415.3M
390.8M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ALT
CCIX
Price
$3.55
$10.65
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
2.8M
109.3K
Earning Date
06-10-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
25.37
N/A
EPS
N/A
N/A
Revenue
$41,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$756,308.50
N/A
P/E Ratio
N/A
$45.59
Revenue Growth
105.00
N/A
52 Week Low
$2.91
$10.46
52 Week High
$7.73
$11.66

Technical Indicators

Market Signals
Indicator
ALT
CCIX
Relative Strength Index (RSI) 30.87 51.02
Support Level $3.39 $10.61
Resistance Level $4.25 $10.71
Average True Range (ATR) 0.24 0.02
MACD -0.10 0.00
Stochastic Oscillator 13.55 66.67

Price Performance

Historical Comparison
ALT
CCIX

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About CCIX Churchill Capital Corp IX Ordinary Shares

Churchill Capital Corp IX is a blank check company.

Share on Social Networks: